Literature DB >> 11883126

Infective complications of central venous catheters in cardiac surgical patients.

B Dhawan1, R Chaudhry, M Hote, A Bhan, P Venugopal.   

Abstract

Prospective randomised study was conducted over a 24 months period in a cardiac surgical intensive care unit to determine the incidence of infection associated with multilumen venous catheters. The influence of various factors including fever, peripheral blood culture, catheter site, catheter usage for monitoring central venous pressure and/inotrope therapy on infection rates were statistically evaluated. A total of 100 catheters submitted to the Microbiology laboratory were bacteriologically examined. Forty-nine of these were inserted into upper body sites, and 51 were inserted into the femoral vein. Twenty-one were triple-lumen catheters. Catheters were removed when a central line was no longer necessary. Catheter tips were cultured by semiquantitative technique for aerobic and anaerobic bacteria. Bacteremia occurred in 3% of catheter insertions; (Enterococcus faecalis, one; Enterobacter spp. One; Acinetobacter spp., one); and catheter colonisation developed in 24%. Neither catheter colonisation nor catheter related infection were associated with any of the risk factors evaluated. Our data indicates that central venous catheters are safe to use in our patients. The inability to identify "risk factors" for catheter infection emphasise the need to maintain a high index of suspicion.

Entities:  

Mesh:

Year:  2001        PMID: 11883126

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

Review 1.  Central venous access sites for the prevention of venous thrombosis, stenosis and infection.

Authors:  Xiaoli Ge; Rodrigo Cavallazzi; Chunbo Li; Shu Ming Pan; Ying Wei Wang; Fei-Long Wang
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 2.  Nosocomial Extracardiac Infections After Cardiac Surgery.

Authors:  Enrico Maria Zardi; Massimo Chello; Domenico Maria Zardi; Raffaele Barbato; Omar Giacinto; Ciro Mastoianni; Mario Lusini
Journal:  Curr Infect Dis Rep       Date:  2022-09-24       Impact factor: 3.663

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.